Pushpakumar et al., 2017)
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
Bn cn ung nc b in gii trong cc trng hp sau: Vn ng mnh, tp th dc cng cao Hc tp v lm vic lin tc trong mi trng nng bc gy nhiu m hi Nn ma nhiu Tiu chy nng Nghin ru B tiu ng khin i tiu nhiu Ri lon n ung B vt bng nng Mt cn bng in gii s khin bn b au u, chng mt, suy nhc c th, chut rt, co tht c, hn m, tn thng no hay thm ch l t vong
Treatment was initiated in mice when they displayed clinical signs characteristic of intestinal tumour burden as defined in the relevant licensing documents (for example, hunching, bloody stools)
Well, science reality has a name: GHK-Cu peptide